Medical Developments International Limited (ASX:MVP)

Market Cap	72.10M
Revenue (ttm)	38.05M
Net Income (ttm)	-29.74M
Shares Out	112.66M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	46.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	324,457
Average Volume	276,354
Open	0.6000
Previous Close	0.5700
Day's Range	0.5850 - 0.6450
52-Week Range	0.3750 - 0.9400
Beta	1.62
RSI	64.78
Earnings Date	Feb 24, 2025

About ASX:MVP

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, po...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 68
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: MVP

Financial Performance

In 2024, ASX:MVP's revenue was 33.15 million, an increase of 2.51% compared to the previous year's 32.34 million. Losses were -40.99 million, 630.8% more than in 2023.